Lataa...
Bispecific antibodies in cancer immunotherapy
Cancer immunotherapy has recently generated much excitement after the continuing success of the immunomodulating anti-CTLA-4 and anti-PD-1 antibodies against various types of cancers. Aside from these immunomodulating antibodies, bispecific antibodies, chimeric antigen receptor T cells, and other te...
Tallennettuna:
| Julkaisussa: | Hum Vaccin Immunother |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5084997/ https://ncbi.nlm.nih.gov/pubmed/27249163 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1187802 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|